References

Unresolved reference

2009 · External reference

Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe

10.1007/s11060-017-2452-6 · 2017 · External reference

Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases

10.1016/j.annonc.2025.06.001 · 2025 · External reference

Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment

10.1053/j.seminoncol.2009.05.005 · 2009 · External reference

A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature

10.1097/cmr.0000000000000274 · 2016 · External reference

Prognostic factors and outcomes in patients with leptomeningeal melanomatosis

10.1215/15228517-2008-062 · 2008 · External reference

Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors

10.1016/j.ejca.2019.05.019 · 2019 · External reference

Carcinomatous meningitis: leptomeningeal metastases in solid tumors

10.4103/2152-7806.111304 · 2013 · External reference

Intracranial metastases from systemic cancer

1978 · External reference

Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features

10.1215/15228517-2007-058 · 2008 · External reference

Leptomeningeal metastases from small cell lung carcinoma

10.1002/cncr.21322 · 2005 · External reference

Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy

10.1002/ijc.30147 · 2016 · External reference

A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer

10.1007/s11060-013-1092-8 · 2013 · External reference

Leptomeningeal metastases

10.1016/s0733-8619(02)00032-4 · 2003 · External reference

Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

10.1038/s41591-020-0918-0 · 2020 · External reference

Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa

10.1007/s11060-013-1244-x · 2013 · External reference

Meningeal carcinomatosis in breast cancer: prognostic factors and outcome

10.1007/s11060-010-0524-y · 2011 · External reference

Survival of breast cancer patients with meningeal carcinomatosis

10.1093/annonc/mdq232 · 2010 · External reference

Leptomeningeal disease in melanoma patients: an update to treatment, challenges, and future directions

10.1111/pcmr.12861 · 2020 · External reference

Breast cancer leptomeningeal metastasis--the role of multimodality treatment

10.1007/s11060-007-9340-4 · 2007 · External reference

Leptomeningeal metastases from solid tumors: a society for neuro-oncology and American Society of Clinical Oncology consensus review on clinical management and future directions

10.1093/neuonc/noae103 · 2024 · External reference

Leptomeningeal disease

10.1016/j.hoc.2021.08.009 · 2022 · External reference

EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours

10.1093/annonc/mdx221 · 2017 · External reference

Comparative evaluation of the diagnostic and prognostic performance of CNSide versus standard cytology for leptomeningeal disease

10.1093/noajnl/vdae071 · 2024 · External reference

Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial

10.1038/s41591-025-03744-1 · 2025 · External reference

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial

10.1001/jama.280.17.1485 · 1998 · External reference

Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy

2017 · External reference

Clinical pharmacology of trastuzumab

10.2174/157488408783329931 · 2008 · External reference

National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities

10.1016/s1470-2045(23)00297-8 · 2023 · External reference

Enzyme linked immunosorbent assay for the quantification of nivolumab and pembrolizumab in human serum and cerebrospinal fluid

10.1016/j.jpba.2018.10.025 · 2019 · External reference

Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders

10.1177/1352458508098268 · 2009 · External reference

Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results

10.1038/s41591-022-02170-x · 2023 · External reference

A murine ommaya xenograft model to study direct-targeted therapy of leptomeningeal disease

10.3791/62033 · 2021 · External reference

Leptomeningeal metastases: a RANO proposal for response criteria

2017 · External reference

The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal

10.1093/neuonc/noz024 · 2019 · External reference

Whole-body 18-F-FDG-PET in patients with leptomeningeal disease and correlation with MRI

10.1097/mnm.0000000000001317 · 2021 · External reference

The sensitivity and specificity of (18)F-FDG PET/CT in spinal leptomeningeal metastases: the synergistic effect of the (18)F-FDG PET-CT to gadolinium-enhanced MRI

10.21037/qims-23-286 · 2023 · External reference

Diagnostics and screening in breast cancer with brain and leptomeningeal metastasis: a review of the literature

10.3390/cancers16213686 · 2024 · External reference

Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma

10.1038/s41467-020-19175-0 · 2020 · External reference

Evaluating cancer of the Central nervous system through next-generation sequencing of cerebrospinal fluid

10.1200/jco.2016.66.6487 · 2016 · External reference

Cell-free DNA extracted from CSF for the molecular diagnosis of pediatric embryonal brain tumors

10.3390/cancers15133532 · 2023 · External reference

Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell-free DNA improves diagnosis of primary CNS lymphoma

10.1111/bjh.18758 · 2023 · External reference

Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine

10.1093/neuonc/noab299 · 2022 · External reference

Genomic characterization of a RET inhibitor-resistant RET fusion-positive lung cancer by CSF cell-free DNA hybrid capture-based sequencing

10.1200/po.20.00188 · 2020 · External reference

Electronic DNA analysis of CSF cell-free tumor DNA to quantify multi-gene molecular response in pediatric high-grade glioma

10.1158/1078-0432.ccr-20-2066 · 2020 · External reference

CSF cell-free DNA EGFR testing using DdPCR holds promise over conventional modalities for diagnosing leptomeningeal involvement in patients with non-small cell lung cancer

10.1016/j.lungcan.2020.07.034 · 2020 · External reference

G-CSF infusion for stem cell mobilization transiently increases serum cell-free DNA and protease concentrations

10.3389/fmed.2020.00155 · 2020 · External reference

Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis

10.1186/s40478-019-0692-8 · 2019 · External reference

Cell-free mitochondrial DNA in the CSF: a potential prognostic biomarker of anti-NMDAR encephalitis

10.3389/fimmu.2019.00103 · 2019 · External reference

Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection

10.1007/s13365-015-0384-5 · 2016 · External reference